HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xu Xia Selected Research

ferruginol

3/2021Retracted: Ferruginol Diterpenoid Selectively Inhibits Human Thyroid Cancer Growth by Inducing Mitochondrial Dependent Apoptosis, Endogenous Reactive Oxygen Species (ROS) Production, Mitochondrial Membrane Potential Loss and Suppression of Mitogen-Activated Protein Kinase (MAPK) and PI3K/AKT Signaling Pathways.
1/2019Ferruginol Diterpenoid Selectively Inhibits Human Thyroid Cancer Growth by Inducing Mitochondrial Dependent Apoptosis, Endogenous Reactive Oxygen Species (ROS) Production, Mitochondrial Membrane Potential Loss and Suppression of Mitogen-Activated Protein Kinase (MAPK) and PI3K/AKT Signaling Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xu Xia Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
10/2018 - 07/2017
3Neoplasms (Cancer)
10/2018 - 11/2011
2Thyroid Neoplasms (Thyroid Cancer)
03/2021 - 01/2019
1Stroke (Strokes)
08/2018
1Brain Ischemia (Cerebral Ischemia)
08/2018
1Transient Ischemic Attack
08/2018
1Infarction (Infarctions)
08/2018
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
08/2018
1Carcinogenesis
07/2017
1Liver Neoplasms (Liver Cancer)
01/2016
1Hepatocellular Carcinoma (Hepatoma)
01/2016
1Glioblastoma (Glioblastoma Multiforme)
11/2011
1Glioma (Gliomas)
11/2011

Drug/Important Bio-Agent (IBA)

3ErbB Receptors (EGF Receptor)IBA
10/2018 - 11/2011
2Mitogen-Activated Protein KinasesIBA
03/2021 - 01/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2021 - 01/2019
2ferruginolIBA
03/2021 - 01/2019
2DiterpenesIBA
03/2021 - 01/2019
2Estrogen ReceptorsIBA
10/2018 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 01/2018
2ParaffinIBA
10/2018 - 01/2018
2Cadherins (E-Cadherin)IBA
10/2018 - 01/2018
2Epidermal Growth Factor (EGF)IBA
10/2018 - 01/2018
2Progesterone Receptors (Progesterone Receptor)IBA
10/2018 - 01/2018
2Indicators and Reagents (Reagents)IBA
07/2017 - 01/2016
1ningdongIBA
03/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Hematoxylin (Haematoxylon)IBA
10/2018
1Eosine Yellowish-(YS) (Eosin)IBA
10/2018
1Coloring Agents (Dyes)IBA
10/2018
1triphenyltetrazoliumIBA
08/2018
1Neuroprotective AgentsIBA
08/2018
1GenisteinIBA
08/2018
1Phytoestrogens (Phytoestrogen)IBA
08/2018
1Biological ProductsIBA
07/2017
1Deubiquitinating EnzymesIBA
07/2017
1EnzymesIBA
07/2017
1DYC-279IBA
01/2016
1Temozolomide (Temodar)FDA LinkGeneric
11/2011
1epidermal growth factor receptor VIIIIBA
11/2011
1cediranib (AZD2171)IBA
11/2011

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2019
1Estrogen Replacement Therapy
08/2018